当前位置: 首页 >> 检索结果
共有 40031 条符合本次的查询结果, 用时 2.0489614 秒

441. Enhanced Analytical Framework for Complex Biological Data: Beyond Principal Component Analysis in Cancer Research.

作者: Yoshiyasu Takefuji.
来源: Gastroenterology. 2025年169卷4期742-743页

442. The Patient Prescription for Integrating Artificial Intelligence Into Gastroenterology Care.

作者: Kate Mason.;Megan Marsiglio.;Sam Jactel.
来源: Gastroenterology. 2025年169卷3期393-395页

443. Associations of Alcohol Consumption and Genetic Predisposition to Hepatic Steatosis With Liver-Related Events: Results From Large Population-Based Cohort Studies.

作者: Hongliang Xue.;Liqing Wang.;Dianjianyi Sun.;Yuankai Wu.;Canqing Yu.;Yating Huang.;Sun On Chan.;Wenhua Ling.;Jun Lv.;Liming Li.;Xu Chen.;Yuanjie Pang.;Chao Yu.
来源: Gastroenterology. 2025年169卷4期705-714.e14页
The new classification for steatotic liver disease identifies 3 phenotypes based on alcohol consumption. The aim of this study was to evaluate the associations between alcohol intake and liver-related events (LREs) across different drinking categories and whether genetic predisposition influences these associations.

444. Reply.

作者: Jinsheng Ding.;Tianxing Zhou.;Jihui Hao.
来源: Gastroenterology. 2025年169卷4期743-744页

445. A Rare Treatable Cause of Dysphagia and Odynophagia in a Lung Transplant Recipient.

作者: Abdillahi Ahmed.;Lehar Khanna.;Anil Sharma.
来源: Gastroenterology. 2025年

446. Revisiting Helicobacter pylori Eradication: Evolving Evidence and Global Implications for Gastric Cancer Prevention.

作者: Zong-Chao Liu.;Wen-Qing Li.
来源: Gastroenterology. 2025年169卷2期205-207页

447. Role of liver transient elastography in detecting cirrhosis with esophageal and gastric varices and evaluating variceal severity.

作者: Chaozhi Wang.
来源: BMC Gastroenterol. 2025年25卷1期379页
To explore the application and clinical value of liver transient elastography (TE) in diagnosing and assessing the degree of liver cirrhosis combined with esophageal and gastric varices (EGV).

448. A systematic review of the epidemiology and risk factors for severity and recurrence of hypertriglyceridemia-induced acute pancreatitis.

作者: Jiongdi Lu.;Zhe Wang.;Wentong Mei.;Kaixin Peng.;Liang Zhang.;Gang Wang.;Kedong Xu.;Zheng Wang.;Yunpeng Peng.;Zipeng Lu.;Xiaolei Shi.;Guotao Lu.;Li Wen.;Feng Cao.; .
来源: BMC Gastroenterol. 2025年25卷1期374页
This systematic review aims to comprehensively assess the epidemiology and identify risk factors associated with the severity and recurrence of hypertriglyceridemia-induced acute pancreatitis (HTG-AP). A search of PubMed, Web of Science, and Cochrane databases was conducted to identify all relevant randomized controlled trials (RCTs), prospective, or retrospective cohort studies on HTG-AP. Data related to epidemiology and risk factors for severity and recurrence of HTG-AP were extracted and analyzed. Seventy-seven studies met the inclusion criteria, comprising 1 RCT, 21 prospective studies, and 55 retrospective studies. A total of 56,617 acute pancreatitis (AP) patients were included, of which 19.99% were diagnosed with HTG-AP (n = 11,315). Compared to non-HTG-AP patients, HTG-AP patients were more likely to be male (68.7% vs. 57.3%) and younger (mean age 41.47 ± 4.32 vs. 50.25 ± 7.70 years). HTG-AP patients exhibited higher mortality rates (up to 20% vs. 15.2%), increased severity (8.3% to 100% vs. 3.8% to 47.2%), and higher recurrence rates (up to 64.8% vs. 23.3%). Analysis of temporal trends from 2002 to 2023 showed a range of HTG-AP prevalence in overall AP patients from 1.6% to 47.6%, with a slight upward trend that was not statistically significant (P = 0.1081). Regional analysis indicated relatively stable prevalence in North America (P = 0.5787), Europe (P = 0.0881), other regions (P = 0.738), while prevalence in China showed a significant increase (P = 0.0119). Thirteen studies investigated risk factors affecting HTG-AP severity, with elevated serum triglyceride (TG) levels associated with increased risk of complications such as pancreatic necrosis, systemic inflammatory response syndrome (SIRS), shock, and multi-organ failure. Additional factors including high neutrophil-to-lymphocyte ratio (NLR), elevated levels of amylase and C-reactive protein (CRP), hypocalcemia, and hypoalbuminemia were also implicated in HTG-AP severity. Smoking history, poor lipid control (TG > 3.1 mmol/L), or recurrent hypertriglyceridemia during follow-up were identified as potential predictors of HTG-AP recurrence. Our findings indicate a stable global prevalence of HTG-AP within AP patients, but a notable increase in China, possibly attributed to socio-economic and dietary factors.

449. Clinical challenges and patient experiences in early-onset colorectal cancer: insights from seven European countries.

作者: Marianna Vitaloni.;Katell Maguet.;Andi Carlan.;Patricia Stack.;Vincent de Jong.;Ross Williams.;Zorana Maravic.
来源: BMC Gastroenterol. 2025年25卷1期378页
The incidence of early-onset colorectal cancer (eoCRC), defined as CRC diagnosed in individuals under 50, is rising globally. Younger patients often face diagnostic delays and receive care pathways designed for older populations. These gaps highlight the need for tailored approaches to diagnosis, treatment, and support.

450. Clinical outcomes of endoscopic retrograde cholangiopancreatography after Billroth II anastomosis: a comparison of gastroscope and duodenoscope.

作者: Kang Ho Lee.;Gwang Hyo Yim.;Jimin Han.;Han Taek Jeong.
来源: BMC Gastroenterol. 2025年25卷1期373页
Endoscopic retrograde cholangiopancreatography (ERCP) in patients with Billroth II anastomosis is challenging due to post-surgical anatomical alterations. This study aims to compare the clinical outcomes of using a duodenoscope and a cap-assisted gastroscope in these patients.

451. Changes in microbial and metabolic profiles of mice fed with long-term high salt diet.

作者: Huiying Tian.;Xiaotang Gao.;Hanlin Du.;Zhuofeng Lin.;Xianen Huang.
来源: BMC Gastroenterol. 2025年25卷1期375页
High salt diet (HSD) has been considered as a risk factor for the development of metabolic disorders. However, less is known about long-term implications of HSD. Therefore, the aim of this study was to conduct a preliminary investigation into the effects of mice feeding with long-term HSD on gut microbial and metabolic profiles.

452. Intravenous sedation during esophagogastroduodenoscopy is associated with a reduced risk of missed gastric cancer.

作者: Isabel Salvador.;Beatriz Arau.;Xavier Andújar.;Carme Ferrer.;Yamile Zabana.;Laura Ruiz.;Montserrat Aceituno.;Fernando Fernández-Bañares.;Maria Esteve.;Carme Loras.
来源: BMC Gastroenterol. 2025年25卷1期377页
Esophagogastroduodenoscopy (EGD) is an effective technique for diagnosing gastric cancer (GC). However, it is estimated that 10% of GCs are unnoticed, constituting missed gastric cancer (MGC). To analyse the incidence of MGC in our area, the characteristics of GC and factors related to MGC were evaluated.

453. Machine learning for predicting all-cause mortality of metabolic dysfunction-associated fatty liver disease: a longitudinal study based on NHANES.

作者: Xueni Wang.;Huihui Chen.;Luqiao Wang.;Wenguang Sun.
来源: BMC Gastroenterol. 2025年25卷1期376页
The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors influencing it. While advanced machine learning algorithms are gaining recognition as effective tools for clinical prediction, their ability to predict all-cause mortality of MAFLD individuals remains uncertain. This study aimed to develop different machine learning models to predict all-cause mortality of MAFLD individuals, compare the predictive performance of these models, and identify the risk factors contributing all-cause mortality, which is crucial for management of MAFLD individuals.

454. Artificial Intelligence in Gastroenterology and Hepatology: Potential and Perils.

作者: Dennis L Shung.;Marietta Iacucci.
来源: Gastroenterology. 2025年169卷3期391-392页

455. Impact of medical therapy on liver transplant eligibility in patients with portopulmonary hypertension: a systematic review.

作者: Matthew T Siuba.;Ahmed Abushamma.;Aman Qureshi.;Shelley Ivary.;Adriano R Tonelli.
来源: Minerva Gastroenterol (Torino). 2025年
Portopulmonary hypertension (PoPH) occurs in roughly 5% of patients evaluated for liver transplant and increases perioperative morbidity and mortality. PoPH patients often succumb to complications of the underlying liver disease, therefore liver transplantation can be a lifesaving intervention. Medical treatment of PoPH optimizes patients for transplantation, but the knowledge on the effect of PH specific therapy on transplant eligibility is limited.

456. Clinical characteristics of MASLD/MetALD/MAFLD/NAFLD and the relative risk analysis on metabolic disorders.

作者: Hong-Ye Peng.;Chun-Li Lu.;Mo Zhao.;Xiao-Qiang Huang.;Shu-Xia Huang.;Zi-Wen Zhuo.;Jing Liu.;Yan-Ping Lu.;Wen-Liang Lv.
来源: BMC Gastroenterol. 2025年25卷1期372页
Our objective was to compare the clinical features of Metabolic dysfunction-associated steatotic liver disease (MASLD) /metabolic alcohol-related liver disease (MetALD)/metabolic associated fatty liver disease (MAFLD)/nonalcoholic fatty liver disease (NAFLD) and the relative risk analysis of metabolic disorders.

457. The HbA1c/HDL-C ratio as a screening indicator of NAFLD in U.S. adults: a cross-sectional NHANES analysis (2017-2020).

作者: Ju Wu.;Wenjing Yu.;Linglong Huang.;Shuangshuang Hou.;Yanan Huang.;Zhihua Huang.;Zhiyuan Dai.;Jiajun Yin.;Zhequn Nie.
来源: BMC Gastroenterol. 2025年25卷1期369页
Non-alcoholic fatty liver disease (NAFLD), a metabolic liver disorder closely associated with obesity and diabetes, urgently requires early screening. This population-based study is the first to explore the relationship between glycemic control and a novel dyslipidemia composite index-the glycated hemoglobin/high-density lipoprotein cholesterol (HbA1c/HDL-C) ratio in individuals with NAFLD and liver fibrosis.

458. Surface area outcomes in EUS-guided liver biopsy: a comparative study of Franseen and Fork-tip needles.

作者: Kotaro Matsumoto.;Shinpei Doi.;Takako Adachi.;Ayako Watanabe.;Nobuhiro Katsukura.;Takayuki Tsujikawa.;Tatsuya Aso.;Mikiko Takahashi.;Kentaro Kikuchi.
来源: BMC Gastroenterol. 2025年25卷1期370页
The practice of endoscopic ultrasound-guided liver biopsy (EUS-LB) is becoming more common due to its proven safety and effectiveness. For accurate diagnosis, it is vital to secure ample tissue specimens. However, gauging the volume of tissue specimens accurately poses a challenge with existing methods. Additionally, determining the most suitable fine-needle biopsy (FNB) needle requires further study. Our aim was to contrast the tissue surface areas obtained using Franseen and Fork-tip needles and to identify factors affecting tissue volume.

459. Comparison of outcomes between surgery and non-surgery after conversion therapy for advanced gastric cancer with unresectable factors: a systematic review and meta-analysis.

作者: Jiaheng Wu.;Xuetian Du.;Yiqiang He.;Shulin Xian.
来源: BMC Gastroenterol. 2025年25卷1期371页
Advanced gastric cancer (AGC) with unresectable factors presents a significant treatment challenge. Conventional treatments such as systemic chemotherapy, radiotherapy, and immunotherapy can delay disease progression but often yield limited outcomes. For stage III-IV gastric cancer with unresectable factors, conversion therapy based on chemotherapy can achieve tumor downstaging, providing a subset of patients with the opportunity for curative surgery. However, the efficacy of multimodal approaches combining chemotherapy, with or without immunotherapy, and conversion surgery compared to chemotherapy alone remains controversial.

460. Association of biological aging and the prevalence of nonalcoholic fatty liver disease: a population-based study.

作者: Gang Liu.;Qingsong Mao.;Xinling Tian.;Chenwei Zhang.;Yukai Zhang.;Jiarong He.;Yuzhe Kong.
来源: BMC Gastroenterol. 2025年25卷1期368页
To examine the relationship between biological aging and the prevalence of NAFLD.
共有 40031 条符合本次的查询结果, 用时 2.0489614 秒